Silverarc Capital Management »

Research Alliance Corp Iii shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9M 360k 10.70

More positions owned by Silverarc Capital Management

Ascendis Pharma A/s Ord Shs (ASND)
Celcuity (CELC)
Cogent Biosciences (COGT)
Urogen Pharma (URGN)
Immunome (IMNM)
Dianthus Therapeutics (DNTH)
Rhythm Pharmaceuticals (RYTM)
Oruka Therapeutics (ORKA)
Monte Rosa Therapeutics (GLUE)
Syndax Pharmaceuticals (SNDX)
Enliven Therapeutics (ELVN)
Immunovant (IMVT)
Erasca (ERAS)
Sagimet Biosciences Com Ser A (SGMT)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Silverarc Capital Management

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii